Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus H Heim

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
JHEP Reports : Innovation in Hepatology|May 30, 2026
Hepatitis C Virus Can Induce Gene Expression Changes Associated with HepatocarcinogenesisTuyana Boldanova, Fredrik Trulsson, Fahim Ebrahimi, et al.
Gastroenterology|January 17, 2012
Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of miceMichael T Dill, Sonja Rothweiler, Valentin Djonov, et al.
Carcinogenesis|August 1, 2013
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53François H T Duong, Michael T Dill, Matthias S Matter, et al.
Cell Metabolism|April 24, 2012
Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1cAsami Hagiwara, Marion Cornu, Nadine Cybulski, et al.
The Oncologist|November 2, 2010
Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I studyJean-François Dufour, Hanno Hoppe, Markus H Heim, et al.
Gastroenterology|June 9, 2012
Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis CMichael T Dill, Zuzanna Makowska, Francois H T Duong, et al.
Gastroenterology|November 30, 2010
Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis CMichael T Dill, Francois H T Duong, Julia E Vogt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patientEva Dazert, Marco Colombi, Tujana Boldanova, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinomaZuzanna Makowska, Tujana Boldanova, David Adametz, et al.
Cancer Cell|December 13, 2017
mTORC2 Promotes Tumorigenesis via Lipid SynthesisYakir Guri, Marco Colombi, Eva Dazert, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
JHEP Reports : Innovation in Hepatology|May 30, 2026
Hepatitis C Virus Can Induce Gene Expression Changes Associated with HepatocarcinogenesisTuyana Boldanova, Fredrik Trulsson, Fahim Ebrahimi, et al.
Gastroenterology|January 17, 2012
Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of miceMichael T Dill, Sonja Rothweiler, Valentin Djonov, et al.
Carcinogenesis|August 1, 2013
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53François H T Duong, Michael T Dill, Matthias S Matter, et al.
Cell Metabolism|April 24, 2012
Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1cAsami Hagiwara, Marion Cornu, Nadine Cybulski, et al.
The Oncologist|November 2, 2010
Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I studyJean-François Dufour, Hanno Hoppe, Markus H Heim, et al.
Gastroenterology|June 9, 2012
Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis CMichael T Dill, Zuzanna Makowska, Francois H T Duong, et al.
Gastroenterology|November 30, 2010
Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis CMichael T Dill, Francois H T Duong, Julia E Vogt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patientEva Dazert, Marco Colombi, Tujana Boldanova, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinomaZuzanna Makowska, Tujana Boldanova, David Adametz, et al.
Cancer Cell|December 13, 2017
mTORC2 Promotes Tumorigenesis via Lipid SynthesisYakir Guri, Marco Colombi, Eva Dazert, et al.
Pageof 15